Raj Denhoy
Stock Analyst at Jefferies
(2.96)
# 1,192
Out of 5,182 analysts
46
Total ratings
68.09%
Success rate
24.45%
Average return
Main Sectors:
Stocks Rated by Raj Denhoy
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ABT Abbott Laboratories | Reiterates: Hold | $120 | $96.00 | +25.00% | 5 | Sep 26, 2024 | |
| EW Edwards Lifesciences | Maintains: Buy | $110 → $130 | $81.44 | +59.63% | 10 | Jul 30, 2021 | |
| PROF Profound Medical | Initiates: Buy | n/a | $7.15 | - | 1 | Sep 15, 2020 | |
| DXCM DexCom | Maintains: Buy | $29 → $31 | $64.62 | -51.64% | 8 | Aug 2, 2018 | |
| AXGN Axogen | Initiates: Buy | $35 | $37.23 | -5.99% | 1 | Nov 30, 2017 | |
| TFX Teleflex | Maintains: Buy | $270 → $295 | $131.95 | +123.57% | 9 | Nov 3, 2017 | |
| LIVN LivaNova | Maintains: Buy | $80 → $91 | $65.81 | +38.28% | 3 | Nov 3, 2017 | |
| LNTH Lantheus Holdings | Maintains: Buy | $22 → $27 | $83.97 | -67.85% | 2 | Nov 3, 2017 | |
| PODD Insulet | Maintains: Buy | $58 → $67 | $200.87 | -66.65% | 7 | Nov 3, 2017 |
Abbott Laboratories
Sep 26, 2024
Reiterates: Hold
Price Target: $120
Current: $96.00
Upside: +25.00%
Edwards Lifesciences
Jul 30, 2021
Maintains: Buy
Price Target: $110 → $130
Current: $81.44
Upside: +59.63%
Profound Medical
Sep 15, 2020
Initiates: Buy
Price Target: n/a
Current: $7.15
Upside: -
DexCom
Aug 2, 2018
Maintains: Buy
Price Target: $29 → $31
Current: $64.62
Upside: -51.64%
Axogen
Nov 30, 2017
Initiates: Buy
Price Target: $35
Current: $37.23
Upside: -5.99%
Teleflex
Nov 3, 2017
Maintains: Buy
Price Target: $270 → $295
Current: $131.95
Upside: +123.57%
LivaNova
Nov 3, 2017
Maintains: Buy
Price Target: $80 → $91
Current: $65.81
Upside: +38.28%
Lantheus Holdings
Nov 3, 2017
Maintains: Buy
Price Target: $22 → $27
Current: $83.97
Upside: -67.85%
Insulet
Nov 3, 2017
Maintains: Buy
Price Target: $58 → $67
Current: $200.87
Upside: -66.65%